Literature DB >> 11824768

Accidental ingestion of alprazolam in 415 dogs.

Tina A Wismer1.   

Abstract

Alprazolam is a benzodiazepine anti-anxiety agent that acts at the limbic, thalamic, and hypothalamic level of the CNS and has anxioytic. sedative, hypnotic, skeletal muscle relaxant, and anticonvulsant properties. A retrospective study was conducted of 415 alprazolam ingestions in dogs reported to the ASPCA Animal Poison Control Center between January 1998 and August 2000: 238 suspected alprazolam toxicoses in dogs were evaluated. Clinical signs were ataxia/disorientation, depression, hyperactivity, vomiting, weakness, tremors, vocalization, tachycardia, tachypnea, hypothermia, diarrhea, and increased salivation that developed within 10-30 min post-ingestion. Treatment included standard decontamination procedures, such as emesis and activated charcoal: the specific benzodiazepine antagonist, flumazenil, may be used for severe CNS depression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11824768

Source DB:  PubMed          Journal:  Vet Hum Toxicol        ISSN: 0145-6296


  4 in total

1.  Effects of alprazolam on capture stress-related serum cortisol responses in Korean raccoon dogs (Nyctereutes procyonoides koreensis).

Authors:  Sun-A Kim; So-Yeong Lee; Junpei Kimura; Nam-Shik Shin
Journal:  J Vet Sci       Date:  2011-03       Impact factor: 1.672

2.  Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogs.

Authors:  Pamela L Tannenbaum; Joanne Stevens; Jacquelyn Binns; Alan T Savitz; Susan L Garson; Steven V Fox; Paul Coleman; Scott D Kuduk; Anthony L Gotter; Michael Marino; Spencer J Tye; Jason M Uslaner; Christopher J Winrow; John J Renger
Journal:  Front Behav Neurosci       Date:  2014-05-16       Impact factor: 3.558

3.  Use of alprazolam to facilitate mare-foal bonding in an aggressive postparturient mare.

Authors:  D M Wong; C J Alcott; J L Davis; K L Hepworth; L Wulf; J H Coetzee
Journal:  J Vet Intern Med       Date:  2015-01-12       Impact factor: 3.333

4.  Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulators.

Authors:  Anthony L Gotter; Susan L Garson; Joanne Stevens; Regina L Munden; Steven V Fox; Pamela L Tannenbaum; Lihang Yao; Scott D Kuduk; Terrence McDonald; Jason M Uslaner; Spencer J Tye; Paul J Coleman; Christopher J Winrow; John J Renger
Journal:  BMC Neurosci       Date:  2014-09-22       Impact factor: 3.288

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.